The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans

Journal of Alternative and Complementary Medicine

Volumn 11, Issue 3, 2005, Pages 401-405

  Park, Hi Joon ^a   Kim, Seung Tae ^a   Yoon, Dong Hak ^a   Jin, Soo Hee ^a   Lee, Su Jin ^a   Lee, Hye Jung ^a   Lim, Sabina ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; GENOMIC DNA;

ACUPUNCTURE; ADULT; ARTICLE; DNA EXTRACTION; GENE FREQUENCY; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING CESSATION; SOUTH KOREA;

ACUPUNCTURE THERAPY; ADULT; FEMALE; HUMANS; KOREA; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SMOKING; SMOKING CESSATION; TAQ POLYMERASE;

EID: 22244451365     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2005.11.401     Document Type: Article

References (30)

1. Lerman C, Shields PG, Wileyto EP, et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002;12:627-634.
2. Evans WE, Relling MV. Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 1999; 286:487-491.
3. He D, Medbo JI, Hostmark AT. Effect of acupuncture on smoking cessation or reduction: An 8-month and 5-year follow-up study. Prev Med 2001;33:364-372.
4. Park HJ, Lim S, Joo WS, et al. Acupuncture prevents 6-hydroxydopamine- induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp Neurol 2003;180:93-98
5. Chae H, Lyoo IK, Lee SJ, et al. An alternative way to individualized medicine: Psychological and physical traits of Sasang typology. J Altern Complement Med 2003;9:519-528.
6. Tang NM, Dong HW, Wang XM, et al. Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture or low dose morphine: Conversion of low responder rats into high responders. Pain 1997;71:71-80.
7. Lee G, Rho S, Shin M, et al. The association of cholecystokinin-A receptor expression with the responsiveness of electroacupuncture analgesic effects in rat. Neurosci Lett 2002; 325:17-20.
8. Lee JM. Dong-Yi-Soo-Se-Bo-Won. Seoul, Korea: Jae Ma Lee, 1894.
9. Choi SH, Yim YB, Rhee JW, et al. Relationship between the Sasang constitution and ACE polymorphism. J Sasang Constitutional Med 1998;10:283-290.
10. Han SK, Chi SE, Choi SM. A study of the analysis of constitutional genes. J Sasang Constitutional Med 2003;15:109-117.
11. Heath AC, Madden PA, Slutske WS, et al. Personality and the inheritance of smoking behavior: A genetic perspective. Behav Genet 1995;25:103-117.
12. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific factors in cigarette smoking. Health Psychol 1999;18:14-20.
13. Noble EP, Blum K, Ritchie T, et al. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991;48:648-654.
14. Thompson J, Thomas N, Singleton A, et al. D2 dopamine receptor gene (DRD2) TaqI A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997;7:479-484.
15. Blum K, Noble EP, Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990;263:2055-2060.
16. Comings DE, Ferry L, Bradshaw-Robinson S, et al. The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics 1996;6:73-79.
17. Noble EP, St Jeor ST, Ritchie T, et al. D2 dopamine receptor gene and cigarette smoking: A reward gene? Med Hypotheses 1994;42:257-260.
18. David S, Niaura R, Papandonatos G, et al. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res 2003;5:935-942.
19. Choi YT. Acupuncture and moxibustion. Seoul, Korea: Jip-Moon-Dang, Seoul, 1991.
20. He D, Medbo JI, Hostmark AT. Effect of acupuncture on smoking cessation or reduction: An 8-month and 5-year follow-up study. Prev Med 2001;33:364-372.
21. Grandy DK, Zhang Y, Civelli O. PCR detection of the Taq1 A RFLP at the DRD2 locus. Hum Mol Genet 1993;2:2197.
22. White AR, Resch KL, Ernst E. A meta-analysis of acupuncture techniques for smoking cessation. Tob Control 1999;8:393-397.
23. White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. Cochrane Database Syst Rev 2002;(2):CD000009.
24. Cottraux JA, Harf R, Boissel JP, et al. Smoking cessation with behavior therapy of acupuncture-a controlled study. Behav Res her 1983;21:417-424.
25. Lamontagne Y, Annable L, Gagnon MA. Acupuncture for smokers: Lack of long-term therapeutic effect in a controlled study. Can Med Assoc J 1980;122:787-790.
26. Spitz MR, Shi H, Yang F, et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998;90:358-363.
27. Comings DE, Rosenthal RJ, Lesieur HR, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996;6:223-234.
28. Wise RA, Rompre PR. Brain dopamine and reward. Annu Rev Psychol 1989;40:191-225.
29. Singleton AB, Thomson JH, Morris CM, et al. Lack of association between the dopamine D2 receptor gene allele DRD2 A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics 1998;8:125-128.
30. Yoshida K, Hamajima N, Kozaki Ki, et al. Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol Biomarkers Prev 2001;10:403-405.